ARE2 Antibody

What is ARE2 and why is it important in research?

ARE2 (also known as SAT1 or YNR019W) is a gene in Saccharomyces cerevisiae that encodes Sterol O-acyltransferase 2 or Sterol-ester synthase 2, a key enzyme that catalyzes the formation of steryl esters . This enzyme belongs to the membrane-bound acyltransferase family and is localized to the endoplasmic reticulum membrane as a multi-pass membrane protein.

ARE2 plays a critical role in sterol metabolism and homeostasis in yeast. Research has demonstrated that deletion of ARE2 reduces sterol ester levels to approximately 25% of normal levels, while disruption of the related gene ARE1 has minimal effect on sterol ester biosynthesis . This makes ARE2 particularly important for understanding lipid metabolism regulation and membrane biology.

What are the typical applications for ARE2 antibody in yeast research?

ARE2 antibody is primarily used for:

• Protein detection via Western Blotting: Enables detection and quantification of ARE2 protein expression levels in wild-type, mutant, or stress-condition yeast samples

• ELISA-based quantitative analysis: Allows precise measurement of ARE2 protein concentration in various experimental conditions

• Localization studies: Can be adapted for immunofluorescence to confirm ER membrane localization

• Protein-protein interaction studies: Used in co-immunoprecipitation experiments to identify binding partners

• Expression profiling: Helps determine ARE2 expression under different nutritional or stress conditions

How should ARE2 antibody be stored and handled for optimal results?

For optimal performance and longevity:

• Store ARE2 antibody at -20°C or -80°C upon receipt

• Avoid repeated freeze-thaw cycles that can degrade the antibody

• When working with the antibody, maintain cold chain conditions using ice

• For longer-term storage at working dilutions, add appropriate preservatives and store at -20°C

• Before use, allow the antibody to equilibrate to room temperature and gently mix (avoid vortexing)

How can ARE2 antibody be used to investigate differential expression of ARE1 and ARE2 genes in yeast?

Research has shown that ARE2 is the major enzyme isoform in wild-type yeast cells growing aerobically, which results from a combination of differential transcription initiation and transcript stability . To investigate this:

Methodological approach:

• Comparative expression analysis:

  • Prepare yeast lysates from wild-type and mutant strains under various growth conditions

  • Run parallel Western blots using both ARE1 and ARE2 antibodies

  • Normalize expression using housekeeping proteins like actin

  • Quantify band intensities using image analysis software

• Transcription vs. protein stability studies:

  • Treat cells with transcription inhibitors (e.g., 1,10-phenanthroline) and collect samples at time intervals

  • Analyze ARE2 protein degradation rate via Western blot

  • Compare with mRNA stability data from RT-qPCR

Research has demonstrated that the half-life of ARE2 mRNA is approximately 12 times longer than that of ARE1 transcript, which contributes to its predominance .

What methodological considerations should be taken when using ARE2 antibody for yeast protein analysis?

Sample preparation optimization:

Western blot considerations:

• Use 10-12% SDS-PAGE gels for optimal resolution of ARE2 (MW: approximately 70 kDa)

• Include positive controls using recombinant ARE2 protein

• For membrane proteins like ARE2, avoid boiling samples (heat at 37°C for 30 minutes instead)

• Add protease inhibitors to prevent degradation during extraction

How can ARE2 antibody be used to study sterol regulation under different growth conditions?

ARE1 and ARE2 genes are oppositely regulated by heme, reflecting their different physiological roles . To study this regulation:

• Experimental design for heme regulation:

  • Culture yeast cells under aerobic and anaerobic conditions

  • Create heme-deficient conditions using appropriate mutants or inhibitors

  • Use Western blot with ARE2 antibody to quantify expression

• Quantification methodology:

  • Normalize ARE2 signal to loading controls

  • Perform statistical analysis across biological replicates

  • Present data as fold-change relative to baseline conditions

Research findings indicate that under heme-deficient growth conditions, ARE1 is upregulated fivefold while ARE2 is down-regulated. Additionally, ARE2 requires the HAP1 transcription factor for optimal expression .

What are common issues when using ARE2 antibody in Western blotting and how can they be resolved?

Problem: Weak or no signal

• Cause: Insufficient protein extraction, protein degradation, or low antibody binding

• Solution: Optimize lysis buffer with additional detergents (0.5-1% Triton X-100) to extract membrane-bound ARE2 effectively; ensure samples remain cold during preparation; increase antibody concentration or incubation time

Problem: High background

• Cause: Non-specific binding or excessive antibody concentration

• Solution: Increase blocking duration (5% BSA in TBST for 2 hours); optimize antibody dilution (try 1:1000 to 1:5000 range); include additional washing steps with 0.1% Tween-20 in TBS

Problem: Multiple bands

• Cause: Cross-reactivity, degradation, or post-translational modifications

• Solution: Confirm specificity using ARE2 knockout yeast strains; add additional protease inhibitors; use freshly prepared samples

How can colocalization studies be performed using ARE2 antibody?

To visualize ARE2 localization in the endoplasmic reticulum membrane:

• Cell fixation and permeabilization protocol:

  • Fix yeast cells with 4% paraformaldehyde for 1 hour

  • Digest cell wall with zymolyase (100μg/ml) for 30 minutes at 30°C

  • Permeabilize with 0.1% Triton X-100 for 5 minutes

• Immunostaining procedure:

  • Block with 5% BSA for 1 hour

  • Incubate with primary ARE2 antibody (1:200 dilution) overnight at 4°C

  • Co-stain with ER markers (e.g., anti-Kar2 antibody)

  • Apply appropriate fluorescent secondary antibodies

  • Mount and image using confocal microscopy

• Controls and validation:

  • Include ARE2 knockout strains as negative controls

  • Use known ER markers for colocalization analysis

  • Perform Z-stack imaging to confirm membrane localization

How can ARE2 antibody be used in studies of lipid droplet formation and dynamics?

Sterol esterification by ARE2 contributes to lipid droplet formation in yeast. To investigate this process:

• Experimental approach:

  • Culture yeast under conditions promoting lipid droplet formation (stationary phase or nitrogen limitation)

  • Stain lipid droplets with BODIPY or Nile Red

  • Perform immunofluorescence with ARE2 antibody

  • Analyze colocalization at lipid droplet formation sites

• Advanced visualization techniques:

  • Use super-resolution microscopy to visualize ARE2 distribution during lipid droplet biogenesis

  • Employ time-lapse imaging with tagged ARE2 to monitor dynamic association with forming lipid droplets

  • Correlate ARE2 abundance (quantified by Western blot) with lipid droplet numbers and sizes

Research findings indicate that ARE2 plays a primary role in esterifying ergosterol (the end product of the sterol pathway), while ARE1 primarily esterifies sterol intermediates , suggesting complex regulatory mechanisms for lipid storage.

What considerations should be taken when adapting yeast ARE2 antibody research to study human homologs?

The yeast ARE2 protein shares homology with human ACAT (Acyl-CoA:cholesterol acyltransferase) enzymes. When transitioning research:

• Sequence homology considerations:

  • Yeast ARE2 exhibits approximately 23% identity to human ACAT

  • This limited homology means ARE2 antibodies will likely not cross-react with human ACAT proteins

  • Design studies comparing conserved vs. divergent functions

• Functional conservation assessment:

  • Design complementation studies expressing human ACAT in ARE2-deficient yeast

  • Use ARE2 antibody to confirm absence of yeast protein

  • Evaluate restoration of sterol esterification activity

• Evolutionary insights:

  • Compare sterol substrate preferences between yeast and human enzymes

  • Investigate regulatory differences in sterol metabolism pathways

  • Study effects of drugs targeting human ACAT on yeast ARE2 function as a model system

How can new antibody technologies enhance ARE2 research?

Recent advances in antibody engineering can be applied to ARE2 research:

• Recombinant antibody development using yeast display:

  • Yeast surface display technology allows for rapid selection of high-affinity antibodies

  • This approach can generate improved ARE2-specific antibodies with:

    • Higher specificity and reduced cross-reactivity

    • Enhanced affinity through directed evolution

    • Better performance in various applications

• Bispecific antibody applications:

  • Creating bispecific antibodies targeting ARE2 and other lipid metabolism enzymes

  • Enables simultaneous detection of multiple proteins in complex pathways

  • Provides tools for studying protein-protein interactions in sterol metabolism

• Enhanced detection methodologies:

  • Developing real-time monitoring systems similar to those used for drug-antibody ratio analysis

  • Creating ARE2 activity-sensing antibody constructs

  • Employing new signal amplification methods for detecting low-abundance ARE2 in specific cellular compartments

How should Western blot data using ARE2 antibody be quantified and normalized?

Recommended quantification workflow:

• Capture digital images using a calibrated imaging system

• Analyze band intensity using software (ImageJ, Bio-Rad Image Lab, etc.)

• Subtract background using local background correction

• Normalize ARE2 signal to appropriate loading controls:

  • Pma1 for membrane proteins

  • GAPDH or actin for general normalization

  • Kar2 for ER-specific normalization

• Present data as relative expression with statistical analysis across replicates

Statistical considerations:

• Use at least three biological replicates

• Apply appropriate statistical tests (t-test for simple comparisons, ANOVA for multiple conditions)

• Report both mean values and measures of variation (standard deviation or standard error)

How can researchers resolve conflicting data between ARE2 protein levels and activity measurements?

When protein expression (measured by ARE2 antibody) doesn't correlate with enzyme activity:

• Methodological approach to resolving discrepancies:

  • Measure ARE2 enzyme activity using sterol esterification assays

  • Quantify ARE2 protein levels via quantitative Western blotting

  • Assess post-translational modifications that might affect activity

  • Investigate potential inhibitors or activators present in the system

• Potential explanations for discrepancies:

  • Post-translational regulation of ARE2 activity

  • Substrate availability limitations

  • Protein mislocalization despite normal expression levels

  • Presence of enzyme inhibitors or required cofactors

• Validation experiments:

  • Use site-directed mutagenesis to create ARE2 variants with altered activity

  • Confirm protein expression with ARE2 antibody

  • Correlate mutations with both expression and activity levels

  • Investigate cellular conditions that might alter the relationship between expression and activity